For years, private company valuations operated in a world that rewarded precision in theory more than alignment with reality. Models were refined, assumptions debated, and outputs carefully constructed — often with limited visibility into how the market itself was actually behaving.
The American Institute of Certified Public Accountants’ 2025 update doesn’t introduce sweeping new rules. Instead, it does something far more impactful: it challenges the valuation community to reconcile its work with how markets truly function today.
Private markets are no longer as opaque as they once were. Secondary transactions, structured liquidity programs, and pre-IPO activity have created a steady stream of observable data points. Investors are signaling value more frequently and more transparently.
The implication is subtle but powerful: valuation is no longer just a technical exercise. It is an interpretation of market behavior.
The firms that adapt fastest will be those that stop asking, “Does the model work?” and start asking, “Does this reflect how capital is actually priced right now?”
There was a time when secondary transactions were treated like background noise. Inconsistent, incomplete, easy to dismiss.
That dismissal is no longer defensible. The 2025 update reframes secondary activity as something closer to a market pulse. Not every transaction is relevant, but many are. And when they are credible, they can carry as much weight as primary financing rounds.
This shift forces a more nuanced question: not whether secondary data should be used, but whether it can be reasonably ignored.
Another quiet but meaningful evolution is the narrowing gap between common and preferred stock valuations.
Historically, large discounts on common equity were often treated as a given, rooted in structural differences like liquidation preferences. But market behavior is telling a different story, especially in later-stage companies where investors are underwriting toward conversion and exit.
The takeaway is not that the gap disappears, but that it must be earned. Assumptions that once passed without challenge now require economic justification.
In other words, valuation is becoming less about convention and more about conviction.
The Option Pricing Method isn’t going away. But its role is changing. The new guidance encourages something that sounds obvious but hasn’t always been practiced: choose the method that best reflects how value will actually be realized.
That may mean scenario-based approaches. It may mean hybrid models. It may mean stepping away from a single-method mindset entirely.
One of the most important themes in the update is calibration — not as a technical step, but as a narrative discipline. Valuations are no longer viewed as isolated snapshots. They are expected to tell a consistent story over time, anchored to real transactions and evolving in a way that makes sense. Abrupt changes, unexplained shifts, or disconnected assumptions are no longer just technical issues. They are credibility issues.
The update also brings a sharper lens to debt and capital structure economics. Book values and shortcuts give way to a more grounded view of how obligations actually behave under different outcomes.
This is where valuation starts to intersect more directly with deal dynamics, negotiation realities, and investor expectations. It’s less about what sits on the balance sheet, and more about how those instruments perform when it matters.
Perhaps one of the more practical outcomes of the update is the alignment between GAAP and 409A valuations. The ability to leverage a well-supported 409A valuation for financial reporting purposes reflects a broader theme: consistency over duplication.
But this is not about reducing rigor. It’s about raising the standard for what “well-supported” truly means.
What the AICPA has introduced is not a new framework, but a new expectation: valuations should behave more like markets.
They should incorporate real data when available. They should evolve logically over time. They should reflect how investors think about risk, return, and outcomes. For companies, boards, and investors, this creates both pressure and opportunity. Pressure, because assumptions will be challenged more directly.
Opportunity, because valuations that are grounded in reality are inherently more defensible, more credible, and ultimately more useful. What replaces it is something more dynamic, more transparent, and far more connected to the world in which capital actually moves.
For more information on this topic, please contact a member of our team.
For decades, access to private markets has been largely reserved for institutional investors and a narrow segment of high-net-worth individuals. Today, that paradigm is being challenged. Recent regulatory signals suggest a meaningful shift, one that could redefine how retail capital participates in private investments. At the center of this evolution is a fundamental question: Are…
As the Financial Times reported on April 2, the U.S. Treasury is urging regulators to convene now on the risks building in private credit—an indication that concerns around governance gaps in the sector are beginning to intensify. Recent redemption constraints weren’t a sign of failure in private credit, but they did bring a long-standing tension…
In today’s constrained capital markets, uncertainty has become a primary driver of value in the global life sciences sector. Biotechnology, pharmaceutical, and medical device companies, particularly those operating in innovation hubs such as the United States, Europe, and Asia-Pacific, are increasingly valued on future milestones rather than historical performance. Shifting capital dynamics are reshaping business…